There were four companies in cities associated with Morris County, New Jersey, that received four FDA inspections in the fourth quarter of 2024, according to reports from the U.S. Food and Drug Administration (FDA).
This is a 33.3% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.
Most of the companies inspected at the time were involved in the Drugs sector. Both the Biologics and Food and Cosmetics sectors sectors tied for second most common type.
There were two companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Bristol-Myers Squibb Company | Drugs | 12/06/2024 | Voluntary Action Indicated (VAI) |
| Morristown Medical Center Blood Bank | Biologics | 11/19/2024 | Voluntary Action Indicated (VAI) |
| Novartis Pharmaceuticals Corporation | Drugs | 11/19/2024 | No Action Indicated (NAI) |
| Pharmvista, Inc. | Food and Cosmetics | 12/04/2024 | No Action Indicated (NAI) |
